Your browser doesn't support javascript.
loading
Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India.
Majumder, Md Anwarul Azim; Singh, Keerti; Johnson, W M S; Rajasundaram, Archana; Gupta, Subir; Gaur, Uma; Kumar, Santosh; Chatterjee, Madhuri; Fazle Rabbi, Ahbab Mohammad; Sangishetti, Vijay Prasad; Rahman, Sayeeda; Campbell, Michael H; Harewood, Heather; Bharatha, Ambadasu; Krishnamurthy, Kandamaran; Kabir, Russell; Parsa, Ali Davod; Mohammmad, Shegufta; Haque, Mainul; Razzaque, Mohammed S.
Afiliación
  • Majumder MAA; Public Health Foundation of Bangladesh, Dhaka, Bangladesh.
  • Singh K; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Johnson WMS; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Rajasundaram A; Department of Anatomy, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India.
  • Gupta S; Department of Anatomy, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India.
  • Gaur U; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Kumar S; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Chatterjee M; Karnavati School of Dentistry, Karnavati University, Ahmedabad, Gujarat, India.
  • Fazle Rabbi AM; Department of Pharmacology, Shri Ramkrishna Institute of Medical Science, Durgapur, West Bengal, India.
  • Sangishetti VP; Department of Population Sciences, University of Dhaka, Dhaka, Bangladesh.
  • Rahman S; Department of Pharmacology, Govt. Medical College, Shivpuri, Madhya Pradesh, India.
  • Campbell MH; School of Medicine, American University of Integrative Sciences (AUIS), Bridgetown, Barbados.
  • Harewood H; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Bharatha A; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Krishnamurthy K; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Kabir R; Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados.
  • Parsa AD; Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford, Essex, UK.
  • Mohammmad S; Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford, Essex, UK.
  • Haque M; BRAC Learning Division, BRAC University, Dhaka, Bangladesh.
  • Razzaque MS; Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia.
J Multidiscip Healthc ; 16: 161-174, 2023.
Article en En | MEDLINE | ID: mdl-36700174
Background: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines. Vaccine-associated side effects influence vaccine hesitancy. This study investigated the prevalence, severity, and onset of side effects following the first dose of COVID-19 vaccines among physicians and dentists working in various healthcare settings across India. Methods: A cross-sectional survey collected self-report data from April to June 2021 on side effects following the first dose of the vaccine. An online validated questionnaire using the Google Docs® platform was circulated via email and social media platforms. Results: More than 40% of participants experienced at least one side effect after the first dose of vaccination; the most common were mild and resolved within three days after vaccination. More than 91% of respondents received the Covishield (AstraZeneca) vaccine; the most prevalent adverse effects were soreness of the injected arm (78.9%), tiredness (71.1%), and fever (54.9%). Logistic regression showed that women were almost 60% less likely to report side effects. Conclusion: Findings supported the safety of the first dose of the COVID-19 vaccine based on relatively few self-limiting side effects, mainly soreness of the injected arm and tiredness. Further research is needed to determine the long-term safety of COVID-19 vaccines, especially after booster doses.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: J Multidiscip Healthc Año: 2023 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: J Multidiscip Healthc Año: 2023 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Nueva Zelanda